Mycophenolate Mofetil in the Treatment of Some Skin Diseases
Authors:
P. Cetkovská; K. Pizinger; V. Resl
Authors‘ workplace:
Dermatovenerologická klinika, FN a LFUK v Plzni
přednosta prof. MUDr. Vladimír Resl, CSc.
Published in:
Čes-slov Derm, 80, 2005, No. 1, p. 11-14
Category:
Pharmacologyand Therapy, Clinical Trials
Overview
Mycophenolate mofetil is used in transplant medicine for prevention of graft rejection. Its good safety profile enables an administration of long term immunosuppressive therapy. In last years it is used also in the treatment of some autoimmune and inflammatory skin diseases, especially, in cases where previous immunosupressive treatment failed or had to be stopped for side effects. Our experience with the long term mycophenolate treatment of epidermolysis bullosa acquisita, systemic lupus erythematosus and generalized chronic psoriasis is described. The mycophenolate induced remission and was tolerated very well in these indications.
Key words:
mycophenolate mofetil – therapy – epidermolysis bullosa acquisita – lupus erythematosus – psoriasis
Labels
Dermatology & STDs Paediatric dermatology & STDsArticle was published in
Czech-Slovak Dermatology
2005 Issue 1
Most read in this issue
- Multicentric Reticulohistiocytosis
- Mycophenolate Mofetil in the Treatment of Some Skin Diseases
- Cutaneous Alternariosis – a Diagnostic and Therapeutic Problem
- Photo(chemo)therapy in Dermatological Treatment